Drugplain

LEQSELVI 8 mg/1

deuruxolitinib phosphate · TABLET, FILM COATED · Sun Pharmaceutical Industries, Inc.

No Recall History
Plain English

LEQSELVI is a tablet, film coated containing deuruxolitinib phosphate at 8 mg/1, taken oral. Manufactured by Sun Pharmaceutical Industries, Inc..

Key Facts

Brand Name
LEQSELVI
Generic Name
deuruxolitinib phosphate
NDC Code (Product)
47335-108
Manufacturer
Sun Pharmaceutical Industries, Inc.
Strength
8 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
NDA217900
Marketing Start
06/25/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

product use issue12 reports
product dose omission issue10 reports
drug ineffective8 reports
therapy cessation8 reports
acne5 reports
headache4 reports
condition aggravated3 reports
fatigue3 reports
nasopharyngitis3 reports
pruritus3 reports

Frequently Asked Questions

What is LEQSELVI used for?

LEQSELVI contains deuruxolitinib phosphate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.

Is LEQSELVI a controlled substance?

LEQSELVI is not classified as a controlled substance by the DEA.

What is the generic name for LEQSELVI?

The generic name for LEQSELVI is deuruxolitinib phosphate. There are no other listed brand versions of deuruxolitinib phosphate.

What is the NDC code for LEQSELVI 8 mg/1?

The NDC (National Drug Code) for LEQSELVI 8 mg/1 is 47335-108, listed by Sun Pharmaceutical Industries, Inc..

Product NDC

47335-108

Package NDC

47335-108-86

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)